Point-of-Care Molecular Diagnostics Market Expected to Reach USD 10.12 Billion by 2030, Driven by Technological Advancements and Growing Geriatric Population - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Point-of-Care Molecular Diagnostics Market Size, Share & Trends Analysis Report by Application (Infectious Diseases, Oncology, Prenatal Testing), Technology, Test Location, End-use, Region, and Segment Forecasts, 2024-2030" report has been added to ResearchAndMarkets.com's offering.

Recent findings suggest an impending upsurge in the global Point-of-Care (POC) Molecular Diagnostics market, with forecasts estimating a valuation of USD 10.12 billion by the year 2030. This relates to a Compound Annual Growth Rate (CAGR) of 2.5% over the period from 2024 to 2030. This boost is attributed to several core factors including an alarming rise in infectious diseases and a considerable expansion in the aged demographic across the globe.

The market analysis indicates a substantial need for POC molecular diagnostics, particularly for infections like COVID-19 and HIV, and to bolster ongoing monitoring in home healthcare settings. Technology advances such as CRISPR and next-generation sequencing (NGS) are playing critical roles in enhancing cancer detection rates and, concurrently, fueling the market demand for oncology POC tests.

With a significant portion of the market share taken by PCR-based technology, the demand for POC diagnostics has seen a noticeable increase, especially for rapid testing in hospital and clinic-based test locations. North America is currently leading the market, while the Asia-Pacific region shows significant growth potential due to enhancements in its healthcare infrastructure and rising cancer awareness.

Key Insights from the Point-of-Care Molecular Diagnostics Market Report

• Rapid and precise diagnostics through POC tests are skyrocketing in acceptance globally.
• Increased home-care diagnostic practices are facilitating the market expansion.
• The PCR-based technology segment of POC molecular diagnostics continues to be a frontrunner.
• North America leads the market while Asia-Pacific exhibits considerable growth potential.

Prominent industry players are emphasizing innovation and initiating pilot programs as part of their strategies for market distinction and are expected to introduce new products that will enhance POC molecular diagnostics offerings.

The detailed report delves into all aspects of the POC molecular diagnostics market, offering key actionable insights for stakeholders and industry participants interested in this rapidly evolving healthcare segment. The research addresses crucial data that underpin strategic decisions and forecasted growth, setting the stage for ongoing and future developments in the POC molecular diagnostics landscape.

For more information about this report visit https://www.researchandmarkets.com/r/awr5hz

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.